文献速递乳腺US

评估B型超声、彩色多普勒血流成像、应变弹性成像及患者年龄对深度学习算法预测乳腺病灶分子亚型的影响

Assessing the Influence of B-US, CDFI, SE, and Patient Age on Predicting Molecular Subtypes in Breast Lesions Using Deep Learning Algorithms.
PubMed 文献 · J Ultrasound Med · 2024-04-06

本研究收集198例患者共2272幅多模态超声图像,用ResNet-18网络基于B型超声、彩色多普勒血流成像和应变弹性成像预测乳腺病灶四种分子亚型。B型超声联合彩色多普勒血流成像的测试集平均准确率提升至85.41%,且40岁以下患者的预测性能优于40岁及以上患者。

要点

  • B型超声联合彩色多普勒血流成像较单用B型超声提升分子亚型预测准确率(74.50%升至85.41%)。
  • B型超声联合应变弹性成像对预测性能改善有限(准确率75.64%)。
  • 40岁以下患者预测准确率90.48%,优于40岁及以上患者的81.96%。

核心结论

  • 多模态超声成像可用于较准确地预测乳腺病灶分子亚型,除B型超声外,彩色多普勒血流成像而非应变弹性成像有助于进一步提升预测性能,且40岁以下患者预测性能明显优于40岁及以上患者。

研究设计与样本

  • 研究纳入198例患者的2272幅多模态超声图像,采用ResNet-18网络,按80%:20%比例将图像分为训练集和测试集,基于B型超声、彩色多普勒血流成像和应变弹性成像预测四种分子亚型,以平均准确率、精确率、召回率、F1分数和混淆矩阵评价测试集性能。

诊断标准与关键数值

  • 基于B型超声,测试集平均准确率74.50%、精确率74.84%、召回率72.48%、F1分数0.73。
  • B型超声联合彩色多普勒血流成像,测试集平均准确率85.41%、精确率85.03%、召回率85.05%、F1分数0.84。
  • B型超声联合应变弹性成像,测试集平均准确率75.64%、精确率74.69%、召回率73.86%、F1分数0.74。
  • 40岁以下患者图像,测试集平均准确率90.48%、精确率90.88%、召回率88.47%、F1分数0.89。
  • 40岁及以上患者图像,测试集平均准确率81.96%、精确率83.12%、召回率80.5%、F1分数0.81。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Our study aims to investigate the impact of B-mode ultrasound (B-US) imaging, color Doppler flow imaging (CDFI), strain elastography (SE), and patient age on the prediction of molecular subtypes in breast lesions.

METHODS: Totally 2272 multimodal ultrasound imaging was collected from 198 patients. The ResNet-18 network was employed to predict four molecular subtypes from B-US imaging, CDFI, and SE of patients with different ages. All the images were split into training and testing datasets by the ratio of 80%:20%. The predictive performance on testing dataset was evaluated through 5 metrics including mean accuracy, precision, recall, F1-scores, and confusion matrix.

RESULTS: Based on B-US imaging, the test mean accuracy is 74.50%, the precision is 74.84%, the recall is 72.48%, and the F1-scores is 0.73. By combining B-US imaging with CDFI, the results were increased to 85.41%, 85.03%, 85.05%, and 0.84, respectively. With the integration of B-US imaging and SE, the results were changed to 75.64%, 74.69%, 73.86%, and 0.74, respectively. Using images from patients under 40 years old, the results were 90.48%, 90.88%, 88.47%, and 0.89. When images from patients who are above 40 years old, they were changed to 81.96%, 83.12%, 80.5%, and 0.81, respectively.

CONCLUSION: Multimodal ultrasound imaging can be used to accurately predict the molecular subtypes of breast lesions. In addition to B-US imaging, CDFI rather than SE contribute further to improve predictive performance. The predictive performance is notably better for patients under 40 years old compared with those who are 40 years old and above.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Liu W, Wang D, Liu L, et al. Assessing the Influence of B-US, CDFI, SE, and Patient Age on Predicting Molecular Subtypes in Breast Lesions Using Deep Learning Algorithms. J Ultrasound Med. 2024. PMID: 38581195. doi:10.1002/jum.16460

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。